Evidence map›Paper›PMID 32086588›Full record

ArticleVirchows Archiv : an international journal of pathology2020

The expression and prognostic role of EBP1 and relationship with AR in HER2+ breast cancer.

Jing Liu, Cong Xu, Danni Xu, Lu Cao, Huiqin Xue, Qingxiang Meng, Yun Niu

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jing LiuDepartment of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Cong XuDepartment of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Danni XuDepartment of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Lu CaoDepartment of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Huiqin XueDepartment of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Qingxiang MengDepartment of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Yun NiuDepartment of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. yunniu0823@126.com.ORCID http://orcid.org/0000-0001-5917-5604
Tianjin Medical University Cancer Institute and Hospital · CN

Funding

National Natural Science Foundation of China 81470119Tianjin Municipal Science and the Technology Commission Research Fund 15JCYBJC27800
6 · The paper itself

Abstract

Human epidermal growth factor receptor (HER)-2 positive (HER2

Indexed as

Adaptor Proteins, Signal TransducingAdultBiomarkers, TumorBreast NeoplasmsDisease-Free SurvivalErb-b2 Receptor Tyrosine KinasesFemaleGene Expression Regulation, NeoplasticHumansMiddle AgedReceptors, AndrogenReceptors, EstrogenReceptors, ProgesteroneRNA-Binding ProteinsAdaptor Proteins, Signal TransducingAR protein, humanBiomarkers, TumorErb-b2 Receptor Tyrosine KinasesPA2G4 protein, humanprogesterone receptor BReceptors, AndrogenReceptors, EstrogenReceptors, ProgesteroneRNA-Binding ProteinsAndrogen receptorErbB3 binding protein 1HER2 positive breast cancerPrognosisTargeted therapy

Identifiers

PMID32086588
OpenAlexW3007582482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.